• Top VA Biller, Quarter 2, 2022• Call Points: Orthopedic Surgeons and Physical Therapists• Led Inservices and Regional Sales Events to promote ERMI• Managed Sales Support Staff for Patient Device Setups• Developed and Executed Business Plan for WPB Territory

• Mastered Dynamic Consultative Selling.• Increased value to clients through product knowledge.• Operating Room Experience.• Bolstered CRM and Business Plan Development skills.

•Make notable contributions to COVID-19 vaccine development efforts.•Improve proficiency in many biochemical and molecular biology assays: cloning, cell culture, transfection, PCR/RT qPCR, protein/antibody purification, ELISA chromatography, mass spectrometry, and high throughput screening robotics.•Enhance ability to design and conduct experiments independently.•Manage logistical and safety operations of the Michael Farzan Laboratory.•Present research at Scripps Institute meetings.

Didactic Medical School Student at the Perelman School of Medicine. Additional training in medical imaging mathematics, physics, computation, and troubleshooting. Research efforts involved MRI cancer detection methods, CT contrast agent development, and intraoperative optical contrast agent formulation.

Lab maintenance, group task designations, chemical and biological experiments. Research focus on Multiple Myeloma patient response predictions and optical imaging development.Publications:Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma. Zhao X, Lwin T, Silva A, Shah B, Tao J, Fang B, Zhang L, Fu K, Bi C, Li J, Jiang H, Meads M, Jacobson T, Silva M, DIstler A, Darville L, Zhang L, Han Y, Rebatchouk D, Di Liberto M, Moscinski L, Koomen J, Dalton W, Shain K, Wang M, Sotomayor E, Tao JNature Communications (2017) 8: 14920.An ex vivo platform for the prediction of clinical response in multiple myeloma. Silva A, Silva M, Sudalagunta P, Distler A, Jacobson T, Collins A, Nguyen T, Song J, Chen D, Chen L, Cubitt C, Baz R, Perez L, Rebatchouk D, Dalton W, Greene J, Gatenby R, Gillies R, Sontag E, Meads M, Shain KCancer Research (2017) 77(12): 3336-3351.Abstracts:A Novel Approach to Study Evolution of Drug Resistance and Optimum Therapy in Multiple Myeloma.Silva A, Jacobson T, Meads M, Distler A, Silva M, Cubitt C, Perez L, Baz R, Gatenby R, Shain K15th International Myeloma Workshop. Rome, Italy. September 2015.A Multidisciplinary Model Predicts Clinical Response in Relapsed Multiple Myeloma.Shain K, Silva A, Jacobson T, Meads M, Distler A, Gatenby R, Baz R, Silva M, Rebatchouk D, Cubitt C57th American Society of Hematology (ASH) Annual Meeting and Exposition. Orlando, FL. December 2015.

Trained in basic science research techniques and developed skills to work successfully and independently in a fast-paced scientific environment.Publications:A preclinical assay for chemosensitivity in multiple myeloma.Khin Z, Ribeiro M, Jacobson T, Hazlehurst L, Perez L, Baz R, Shain K, Silva ACancer Research (2014) 74(1): 56-67.An organotypic high throughput system for characterization of drug sensitivity of primary multiple myeloma cells.Silva A, Jacobson T, Meads M, Distler A, Shain KJournal of Visualized Experiments (2015) (101).Abstracts:Evolutionary Dynamics and Optimal Management of High-risk Multiple MyelomaSilva A, Khin Z, Jacobson T, Shain KAmerican Association for Cancer Research (AACR) Precision Medicine Series: Drug Sensitivity and Resistance: Improving Cancer Therapy. Orlando, FL. June 2014.

Work Dates: Present, 10/2020 - 01/2021, 03/2011 - 08/2011Commission sales position in retail.Showing exemplary teamwork, marketing, and advertising ability. Regular recipient of highest weekly sales award.

Composer and performer for recording artists. Completed movie orchestrations for full-length films. Aided in production and branding of local artists.